Kamla Lifesciences Limited - pharma in Boisar, Maharashtra, India. FY 2026 financials & compliance.
CIN U24233MH2012PLC228772 Incorporated 27 March 2012 ROC Mumbai HQ Boisar, Maharashtra, India
Active Public Limited Company pharma MSME · Medium
Revenue · FY 2025
₹85.4 Cr
▲ 82% YoY
Net loss · FY 2025
₹1.65 Cr
Net margin -1.9%
EBITDA · FY 2025
₹14.58 Cr
EBITDA margin 17.1%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹30 Cr
Issued & subscribed
Open charges
₹65 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
221
Provident fund records

About Kamla Lifesciences Limited

Data last updated:

Kamla Lifesciences Limited is a public limited company based in Boisar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2012PLC228772. Its GSTIN is 27AAECK7593H1Z2 (Maharashtra).

The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹30 Cr. It was formerly known as Kamla Lifesciences Private Limited. It is led by directors including Digambar Jaikishan Zawar (Managing Director) and Milind Balwant Save.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No G – 84/1 MIDC Tarapur Boisar, Maharashtra, India – 401506.

As per the financials filed for FY 2025, the company reported a revenue of ₹85.4 Cr, a growth of 82% compared to the previous year. For the same year it recorded a net loss of ₹1.65 Cr (net margin -1.9%) and EBITDA of ₹14.58 Cr (EBITDA margin 17.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.

The company has about 221 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

As per MCA filings, the company has open charges of ₹65 Cr on record.

Kamla Lifesciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0024422). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kamallifescience.com.

Company details

CIN U24233MH2012PLC228772
Registration Number 228772
Incorporation Date 27 March 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-17-0024422

Name history

Kamla Lifesciences has undergone 2 name changes throughout its history. The company was previously known as Kamla Lifesciences Limited, and Kamla Lifesciences Private Limited. The current legal name is Kamla Lifesciences Limited.

Company NameStatus
Kamla Lifesciences LimitedCurrent
Kamla Lifesciences Private LimitedPrevious

CIN history

Kamla Lifesciences has one previous CIN (Corporate Identification Number): U24233MH2012PTC228772. The current CIN is U24233MH2012PLC228772, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24233MH2012PLC228772Current
U24233MH2012PTC228772Previous

Recognitions & Rankings of Kamla Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-17-0024422

Contact details

Kamla Lifesciences Limited's registered office is in Boisar, Maharashtra. Its website is kamallifescience.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No G – 84/1 MIDC Tarapur Boisar, Maharashtra, India – 401506
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Kamla Lifesciences Limited, buy the company report.

Comprehensive company report
Kamla Lifesciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Kamla Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Kamla Lifesciences Limited, buy the company report.

Financials of Kamla Lifesciences Limited

FY 2025 filings available

Kamla Lifesciences Limited reported revenue of ₹85.4 Cr (up 82% YoY) for FY 2025.

Revenue · FY 2025
₹85.4 Cr ▲ 82%
Net loss · FY 2025
₹1.65 Cr margin -1.9%
EBITDA · FY 2025
₹14.58 Cr margin 17.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 82%
3 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 873%
3 years · compounded
▼ 24%

Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 82% growth in the latest year. EBITDA rose 873% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹85.4 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹14.58 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.65 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin17.1%
Net Profit Margin-1.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Kamla Lifesciences Limited, buy the company report.

Board of directors of Kamla Lifesciences Limited

Kamla Lifesciences has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Milind Balwant SaveDirector04 Jan 201610 Years 10 MonthsCurrent
Digambar Jaikishan ZawarManaging Director27 Mar 201214 Years 7 MonthsCurrent
Pushkar Digambar ZawarAdditional Director03 Feb 20260 Years 9 MonthsCurrent
Ketan Baldevdas MistryDirector19 Jun 20233 Years 5 MonthsCurrent
Dilip Vasudeo GuptaDirector19 Jun 20233 Years 5 MonthsCurrent

Peer comparison

Kamla Lifesciences Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kamla Lifesciences Limitedthis company₹85.4 Cr (FY 2025)-₹1.65 Cr-1.9%82.0%221Boisar, Maharashtra, India
Aerol Formulations Private Limited₹55.39 Cr (FY 2025)11.0%New Delhi, Delhi, India
Sndev Healthcare Limited₹55.17 Cr (FY 2025)14.0%Kandivlai West, Maharashtra, India
Cu-V-Kar Genetic Medicine Private Limited₹55.11 Cr (FY 2024)38.0%Chennai, Tamil Nadu, India
Vim Meditech Private Limited₹53.98 Cr (FY 2024)13.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Kamla Lifesciences Limited, buy the company report.

Auditor

Kamla Lifesciences Limited is audited by Raamas & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Raamas & AssociatesFY 2023124011W

Shareholding

The shareholding of Kamla Lifesciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Kamla Lifesciences Limited, buy the company report.

Charges & borrowings

Open charges
₹65 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹65.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Jul 2021100471519Hdfc Bank Limited₹25 CrOpen
23 Aug 2019100284917Hdfc Bank Limited₹5 CrOpen
23 Aug 2019100286161Hdfc Bank Limited₹15 CrOpen
09 Aug 2019100283107Hdfc Bank Limited₹20 CrOpen

To see the full charge records of Kamla Lifesciences Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Kamla Lifesciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Kamla Lifesciences has 2 subsidiary companies and 5 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

2
Subsidiary companies
5
Associated companies
Key subsidiaries
Company NameCINShares held
Kamford Healthcare Private LimitedU24239MH2019PTC331192
KLL Healthcare Private LimitedU24299MH2021PTC362414

To see the full group structure of Kamla Lifesciences Limited, buy the company report.

Employees & EPFO

Kamla Lifesciences Limited has a workforce of 221 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
221
Active EPFO establishments
1
Employee growth
11.6%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27221
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Kamla Lifesciences Limited, buy the company report.

GST

Kamla Lifesciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECK7593H1Z2MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Kamla Lifesciences Limited, buy the company report.

Recent activity

Kamla Lifesciences Limited has 8 board changes on record since 2012: 5 appointments and 3 cessations. The latest: Pushkar Digambar Zawar was appointed as Additional Director on 03 Feb 2026.

Charges
A charge with Hdfc Bank Limited of Rs. 25.00 Cr registered on 08 Jul 2021 with Charge ID 100471519 was modified on 21 Oct 2026.
Appointed
Pushkar Digambar Zawar was appointed as Additional Director.
AGM
Kamla Lifesciences Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kamla Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Dilip Vasudeo Gupta ceased to be Additional Director.
Ceased
Ketan Baldevdas Mistry ceased to be Additional Director.
Appointed
Dilip Vasudeo Gupta was appointed as Director.
Appointed
Ketan Baldevdas Mistry was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Cr with Charge ID 100471519 was registered on 08 Jul 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 100284917 was registered on 23 Aug 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Cr with Charge ID 100286161 was registered on 23 Aug 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.00 Cr with Charge ID 100283107 was registered on 09 Aug 2019.

4 earlier events are in the company report.

Frequently asked questions

Kamla Lifesciences is an active public limited company based in Boisar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 2012 (14+ years old) and is registered under CIN U24233MH2012PLC228772.

Kamla Lifesciences has 5 current directors:

The latest financial statements of Kamla Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Kamla Lifesciences is 27AAECK7593H1Z2, registered in Maharashtra.

The CIN (Corporate Identification Number) of Kamla Lifesciences is U24233MH2012PLC228772. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kamla Lifesciences was incorporated on 27 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Kamla Lifesciences by revenue are Aerol Formulations Private Limited, Sndev Healthcare Limited, Cu-V-Kar Genetic Medicine Private Limited, Vim Meditech Private Limited, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Pushkar Digambar Zawar was appointed as Additional Director on 03 Feb 2026. Dilip Vasudeo Gupta ceased to be Additional Director on 29 Sep 2023. Ketan Baldevdas Mistry ceased to be Additional Director on 29 Sep 2023. Kamla Lifesciences has 8 board changes on record in total.

Yes, Kamla Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-17-0024422).

Kamla Lifesciences can be reached through the website kamallifescience.com. Its registered office is in Boisar, Maharashtra, India.

The registered office of Kamla Lifesciences is at Plot No G – 841 MIDC Tarapur Boisar, Maharashtra, India – 401506.